Skip to main content
Log in

Preoperative predictors of liver decompensation after mini-invasive liver resection

  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

Abstract

Background

Post-hepatectomy liver failure (PHLF) represents the most frequent complication after liver surgery, and the most common cause of morbidity and mortality. Aim of the study is to identify the predictors of PHLF after mini-invasive liver surgery in cirrhosis and chronic liver disease, and to develop a model for risk prediction.

Methods

The present study is a multicentric prospective cohort study on 490 consecutive patients who underwent mini-invasive liver resection from the Italian Registry of Mini-invasive Liver Surgery (I go MILS). Retrospective additional biochemical and clinical data were collected.

Results

On 490 patients (26.5% females), PHLF occurred in 89 patients (18.2%). The only independent predictors of PHLF were Albumin-Bilirubin (ALBI) score (OR 3.213; 95% CI 1.661–6.215; p < .0.0001) and presence of ascites (OR 3.320; 95% CI 1.468–7.508; p = 0.004). Classification and regression tree (CART) modeling led to the identification of three risk groups: PHLF occurred in 23/217 patients with ALBI grade 1 (10.6%, low risk group), in 54/254 patients with ALBI score 2 or 3 and absence of ascites (21.3%, intermediate risk group) and in 12/19 patients with ALBI score 2 or 3 and evidence of ascites (63.2%, high risk group), p < 0.0001. The three groups showed a corresponding increase in postoperative complications (20.0%, 27.5% and 66.7%), Comprehensive Complication Index (5.1 ± 11.1, 6.0 ± 10.9 and 18.8 ± 18.9) and hospital stay (6.0 ± 4.0, 6.0 ± 6.0 and 8.0 ± 5.0 days).

Conclusion

The risk of PHLF can be stratified by determining two easily available preoperative factors: ALBI and ascites. This model of risk prediction offers an objective instrument for a correct clinical decision-making.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

PHLF:

Post-hepatectomy liver failure

MILS:

Mini-invasive liver surgery

HCC:

Hepatocellular carcinoma

CCC:

Mass-forming cholangiocarcinoma

ALBI:

Albumin-Bilirubin score

LR:

Liver resection

BMI:

Body Mass Index

CART:

Classification and regression tree analysis

ALPPS:

Associating liver partitioning and portal vein ligation for staged hepatectomy

ISGLS:

International Study Group of Liver Surgery

PH:

Portal hypertension

MELD:

Model for end-stage liver disease

DCC:

Dindo–Clavien classification

CCI:

Comprehensive Complication Index

IQR:

Interquartile range

AUC:

Area under curve

MCAR:

Missing completely at random

CHAID:

Chi-square automatic interaction detector

References

  1. Silberhumer GR, Paty PB, Temple LK et al (2015) Simultaneous resection for rectal cancer with synchronous liver metastasis is a safe procedure. Am J Surg 209:935–942

    Article  Google Scholar 

  2. Sposito C, Di Sandro S, Brunero F et al (2016) Development of a prognostic scoring system for resectable hepatocellular carcinoma. World J Gastroenterol 22:8194–8202

    Article  Google Scholar 

  3. Lafaro K, Buettner S, Maqsood H et al (2015) Defining post hepatectomy liver insufficiency: where do we stand? J Gastrointest Surg 19:2079–2092

    Article  Google Scholar 

  4. van den Broek MA, Olde Damink SW, Dejong CH et al (2008) Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment. Liver Int 28:767–780

    Article  Google Scholar 

  5. Skrzypczyk C, Truant S, Duhamel A et al (2014) Relevance of the ISGLS definition of posthepatectomy liver failure in early prediction of poor outcome after liver resection: study on 680 hepatectomies. Ann Surg 260:865–870

    Article  Google Scholar 

  6. EASL-EORTC clinical practice guidelines (2012) management of hepatocellular carcinoma. J Hepatol 56:908–943

    Article  Google Scholar 

  7. Citterio D, Facciorusso A, Sposito C et al (2016) Hierarchic interaction of factors associated with liver decompensation after resection for hepatocellular carcinoma. JAMA Surg 151:846–853

    Article  Google Scholar 

  8. Delis SG, Bakoyiannis A, Biliatis I et al (2009) Model for end-stage liver disease (MELD) score, as a prognostic factor for post-operative morbidity and mortality in cirrhotic patients, undergoing hepatectomy for hepatocellular carcinoma. HPB (Oxford) 11:351–357

    Article  Google Scholar 

  9. Nanashima A, Abo T, Arai J et al (2013) Functional liver reserve parameters predictive for posthepatectomy complications. J Surg Res 185:127–135

    Article  Google Scholar 

  10. Zou H, Yang X, Li QL et al (2018) A comparative study of albumin-bilirubin score with child-pugh score, model for end-stage liver disease score and indocyanine green R15 in predicting posthepatectomy liver failure for hepatocellular carcinoma patients. Dig Dis 36:236–243

    Article  Google Scholar 

  11. European Association for the Study of the Liver (2018) EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 69:182–236

    Article  Google Scholar 

  12. Morise Z, Ciria R, Cherqui D et al (2015) Can we expand the indications for laparoscopic liver resection? A systematic review and meta-analysis of laparoscopic liver resection for patients with hepatocellular carcinoma and chronic liver disease. J Hepatobiliary Pancreat Sci 22:342–352

    Article  Google Scholar 

  13. Sposito C, Battiston C, Facciorusso A et al (2016) Propensity score analysis of outcomes following laparoscopic or open liver resection for hepatocellular carcinoma. Br J Surg 103:871–880

    Article  CAS  Google Scholar 

  14. Han HS, Shehta A, Ahn S et al (2015) Laparoscopic versus open liver resection for hepatocellular carcinoma: case-matched study with propensity score matching. J Hepatol 63:643–650

    Article  Google Scholar 

  15. Aldrighetti L, Guzzetti E, Pulitano C et al (2010) Case-matched analysis of totally laparoscopic versus open liver resection for HCC: short and middle term results. J Surg Oncol 102:82–86

    Article  Google Scholar 

  16. Cheung TT, Dai WC, Tsang SH et al (2016) Pure laparoscopic hepatectomy versus open hepatectomy for hepatocellular carcinoma in 110 patients with liver cirrhosis: a propensity analysis at a single center. Ann Surg 264:612–620

    Article  Google Scholar 

  17. Morise Z (2015) Perspective of laparoscopic liver resection for hepatocellular carcinoma. World J Gastrointest Surg 7:102–106

    Article  Google Scholar 

  18. Aldrighetti L, Ratti F, Cillo U et al (2017) Diffusion, outcomes and implementation of minimally invasive liver surgery: a snapshot from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry. Updates Surg 69:271–283

    Article  Google Scholar 

  19. Rahbari NN, Garden OJ, Padbury R et al (2011) Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 149:713–724

    Article  Google Scholar 

  20. Bruix J, Sherman M (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020–1022

    Article  Google Scholar 

  21. Malinchoc M, Kamath PS, Gordon FD et al (2000) A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31:864–871

    Article  CAS  Google Scholar 

  22. Johnson PJ, Berhane S, Kagebayashi C et al (2015) Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol 33:550–558

    Article  Google Scholar 

  23. Pang YY (2000) The Brisbane 2000 terminology of liver anatomy and resections. HPB 2:333–339. (HPB (Oxford) 2002; 4:99–100)

    Article  Google Scholar 

  24. Kawaguchi Y, Fuks D, Kokudo N et al (2018) Difficulty of laparoscopic liver resection: proposal for a new classification. Ann Surg 267:13–17

    Article  Google Scholar 

  25. Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213

    Article  Google Scholar 

  26. Slankamenac K, Nederlof N, Pessaux P et al (2014) The comprehensive complication index: a novel and more sensitive endpoint for assessing outcome and reducing sample size in randomized controlled trials. Ann Surg 260:757–762

    Article  Google Scholar 

  27. Rubin DB (1987) Multiple imputation for nonresponse in surveys. Wiley, New York

    Book  Google Scholar 

  28. Harper PR (2005) A review and comparison of classification algorithms for medical decision making. Health Policy 71:315–331

    Article  Google Scholar 

  29. Cescon M, Colecchia A, Cucchetti A et al (2012) Value of transient elastography measured with FibroScan in predicting the outcome of hepatic resection for hepatocellular carcinoma. Ann Surg 256:706–712

    Article  Google Scholar 

  30. Cipriani F, Fantini C, Ratti F et al (2018) Laparoscopic liver resections for hepatocellular carcinoma: can we extend the surgical indication in cirrhotic patients? Surg Endosc 32:617–626

    Article  Google Scholar 

  31. Berardi G, Van CS, Fretland AA et al (2017) Evolution of laparoscopic liver surgery from innovation to implementation to mastery: perioperative and oncologic outcomes of 2,238 patients from 4 European Specialized Centers. J Am Coll Surg 225:639–649

    Article  Google Scholar 

  32. Andreatos N, Amini N, Gani F et al (2017) Albumin-bilirubin score: predicting short-term outcomes including bile leak and post-hepatectomy liver failure following hepatic resection. J Gastrointest Surg 21:238–248

    Article  Google Scholar 

Download references

Acknowledgements

The authors thank The Italian Group of MILS (I Go MILS) registry and all collaborators who equally contributed to this work.

All Collaborators of the I Go MILS Group listed below are coworkers of the study and contributed to acquisition of data, article review for intellectual content and final approval of the version to be published:

Adelmo Antonucci (Policlinico di Monza, Monza, Italy, e-mail: adelmo.antonucci@policlinicodimonza.it), Francesco Ardito (A. Gemelli, IRCCS, Catholic University of the Sacred Heart, Rome, Italy, e-mail: francesco.ardito@unicatt.it), Carlo Battiston (Fondazione IRCCS Istituto Nazionale Tumori di Milano, Milan, Italy, e-mail: carlo.battiston@istitutotumori.mi.it), Giulio Belli (SM Loreto Nuovo Hospital, Naples, Italy, e-mail: giubelli@unina.it), Stefano Berti (Ospedale Civile S. Andrea, La Spezia, Italy, e-mail: stefano.berti@asl5.liguria.it), Ugo Boggi (AOU Pisana, Pisa, Italy, e-mail: u.boggi@med.unipi.it), Alberto Brolese (S. Chiara Hospital, Trento, Italy, e-mail: alberto.brolese@apss.tn.it), Fulvio Calise (Pinetagrande hospital, Castel Volturno, Italy, e-mail: fulvio.calise@aocardarelli.it), Graziano Ceccarelli, (San Donato Hospital, Arezzo, Italy, e-mail: graziano.ceccarelli@usl8.toscana.it), Michele Colledan (AO Papa Giovanni XXIII, Bergamo, Italy, e-mail: mcolledan@asst-pg23.it), Andrea Coratti (AOU Careggi, Florence, Italy, e-mail: corattia@aou-careggi.toscana.it), Stefano Di Sandro (ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy, e-mail: stefano.disandro@ospedaleniguarda.it), Ludovica Ferrara (University of Parma, Parma, Italy), Antonio Floridi (AO Ospedale Maggiore, Crema, Italy), Antonio Frena (Central Hospital, Bolzano, Italy, e-mail: antonio.frena@asbz.it), Antonio Giuliani, (AO R. N. Cardarelli, Naples, Italy), Gian Luca Grazi (Istituto Nazionale Tumori Regina Elena, Rome, Italy, e-mail: glgrazi@chirurgiadelfegato.it), Enrico Gringeri (University of Padua, Padova, Italy, e-mail: enrico.gringeri@unipd.it), Guido Griseri (San Paolo Hospital, Savona, Italy, e-mail: g.griseri@asl2.liguria.it), Salvatore Gruttadauria (Mediterranean Institute for Transplantation and Specialization Therapies IRCCS-ISMETT, Palermo, Italy, e-mail: sgruttadauria@ismett.edu), Silvio Guerriero (San Martino Hospital, Belluno, Italy, e-mail: silvio.guerriero@ulss.belluno.it), Elio Jovine (Ospedale Maggiore, Bologna, Italy, e-mail: elio.jovine@ausl.bologna.it), Giovanni Battista Levi Sandri (S. Camillo Hospital, Rome, Italy, e-mail: gblevisandri@gmail.com), Paolo Magistri (University of Modena and Reggio Emilia, Italy, e-mail: paolo.magistri@unimore.it), Pietro Maida (Villa Betania Hospital, Napoli, Italy), Pietro Mezzatesta (Casa di Cura La Maddalena, Palermo, Italy, e-mail: mezzatesta@lamaddalenanet.it), Giuseppe Navarra (AOU Policlinico G. Martino, Messina, Italy, e-mail: giuseppe.navarra@polime.it), Amilcare Parisi (AO Santa Maria di Terni, Terni, Italy, e-mail: a.parisi@ospterni.it), Antonio Pinna (Digestive Disease Institute at Cleveland Clinic Abu Dhabi), Francesca Ratti, (IRCCS San Raffaele Hospital, Milan, Italy, e-mail: ratti.francesca@hsr.it), Paolo Reggiani, (IRCCS Ospedale Maggiore Policlinico di Milano, Milan, Italy, e-mail: paolo.reggiani@policlinico.mi.it), Raffaele Romito (Ospedale Maggiore Novara, Italy, e-mail: raffele.romito@maggioreosp.novara.it), Andrea Ruzzenente (University of Verona, Italy, e-mail: andrea.ruzzenente@univr.it), Nadia Russolillo (Mauriziano Umberto I Hospital, Torino, Italy, e-mail: nadia.russolillo@libero.it), Roberto Santambrogio (AO San Paolo, Milan, Italy, e-mail: roberto.santambrogio@asst-santipaolocarlo.it), Giovanni Sgroi (AO Treviglio-Caravaggio, Treviglio, Italy, e-mail: giovanni_sgroi@asst-bgovest.it), Abdallah Slim (AO Desio e Vimercate, Vimercate, Italy, e-mail: abdallah.slim@aovimercate.org), Guido Torzilli (Istituto Clinico Humanitas, Rozzano, Italy, e-mail: guido.torzilli@hunimed.eu), Leonardo Vincenti (AOU Consorziale Policlinico, Bari, Italy), Fausto Zamboni (Brotzu Hospital, Cagliari, Italy, e-mail: faustozamboni@yahoo.it).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vincenzo Mazzaferro.

Ethics declarations

Disclosures

Carlo Sposito, Michela Monteleone, Luca Aldrighetti, Umberto Cillo, Raffaele Dalla Valle, Alfredo Guglielmi, Giuseppe Maria Ettorre, Alessandro Ferrero, Fabrizio Di Benedetto, Giorgio Ettore Rossi, Luciano De Carlis, Felice Giuliante, and Vincenzo Mazzaferro have no conflicts of interest or financial ties to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 15 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sposito, C., Monteleone, M., Aldrighetti, L. et al. Preoperative predictors of liver decompensation after mini-invasive liver resection. Surg Endosc 35, 718–727 (2021). https://doi.org/10.1007/s00464-020-07438-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-020-07438-2

Keywords

Navigation